{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:07:42Z","timestamp":1791443262461,"version":"4.3.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Science and Technology Major Project of China","award":["2017ZX09304027"],"award-info":[{"award-number":["2017ZX09304027"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81571977"],"award-info":[{"award-number":["81571977"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81301420"],"award-info":[{"award-number":["81301420"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Science and Technology Major Project of China","award":["2017ZX10202101"],"award-info":[{"award-number":["2017ZX10202101"]}]},{"name":"the Medical Science Support Program of the Shanghai Science and Technology Committee","award":["16411960400"],"award-info":[{"award-number":["16411960400"]}]},{"name":"the Medical Guidance Support Project of Shanghai Science and Technology Commission","award":["17411969600"],"award-info":[{"award-number":["17411969600"]}]},{"name":"the Shanghai Rising stars of Medical Talent Youth Development Program","award":["2019-72"],"award-info":[{"award-number":["2019-72"]}]},{"name":"the project of Shanghai Municipal Key Clinical Specialty","award":["shslczdzk01102"],"award-info":[{"award-number":["shslczdzk01102"]}]},{"name":"the Shanghai Municipal Commission of Health and Family Planning","award":["20164Y0015"],"award-info":[{"award-number":["20164Y0015"]}]},{"name":"the academy level project of Shanghai Public Health Clinical Center","award":["KY-GW-2019-13"],"award-info":[{"award-number":["KY-GW-2019-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberculosis (Tb) is the most frequent opportunistic infection among people living with HIV infection. The impact of Tb co-infection in the establishment and maintenance of the HIV reservoir is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We enrolled 13 HIV-infected patients with microbiologically confirmed Tb and 10 matched mono-HIV infected controls. Total HIV DNA in peripheral blood mononuclear cells (PBMCs), plasma interleukin-7 (IL-7) concentrations and the activities of indoleamine 2,3-dioxygenase (IDO) were measured for all the participants prior to therapy and after antiretroviral therapy (ART).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After a duration of 16 (12, 22) months\u2019 ART, patients co-infected with Tb who were cured of Tb maintained higher levels of HIV DNA compared with mono-HIV infected patients [2.89 (2.65- 3.05) log\n                      <jats:sub>10<\/jats:sub>\n                      copies\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells vs. 2.30 (2.11\u20132.84) log\n                      <jats:sub>10<\/jats:sub>\n                      copies\/10\n                      <jats:sup>6<\/jats:sup>\n                      cells,\n                      <jats:italic>P\u2009<\/jats:italic>\n                      =\u20090.008]. The levels of on-ART HIV DNA were positively correlated with the baseline viral load (\n                      <jats:italic>r\u2009<\/jats:italic>\n                      =\u20090.64,\n                      <jats:italic>P\u2009<\/jats:italic>\n                      =\u20090.02) in Tb co-infected group. However, neither plasma IL-7 concentration nor plasma IDO activity was correlated with the level of on-ART HIV DNA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Tb co-infection was associated with the increased surrogate marker of the HIV reservoir, while its mechanism warrants further examination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-020-00320-0","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T10:03:12Z","timestamp":1603101792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mycobacterium tuberculosis co-infection is associated with increased surrogate marker of the HIV reservoir"],"prefix":"10.1186","volume":"17","author":[{"given":"Jingna","family":"Xun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangkai","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinzhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luman","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjia","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corky","family":"Steinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"320_CR1","doi-asserted-by":"crossref","unstructured":"AM S. World Health Organization. HIV\/AIDS., 2017. http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en\/. MMWR Morb Mortal Wkly Rep (2017) 66: 813-814.","DOI":"10.15585\/mmwr.mm6630a4"},{"issue":"2","key":"320_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/QAI.0000000000000960","volume":"72","author":"AE Siddiqi","year":"2016","unstructured":"Siddiqi AE, Hall HI, Hu X, Song R. Population-based estimates of life expectancy after HIV diagnosis: United States 2008-2011. J Acquir Immune Defic Syndr. 2016;72(2):230\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"320_CR3","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1097\/QAI.0b013e3182948d82","volume":"63","author":"H Zhu","year":"2013","unstructured":"Zhu H, Napravnik S, Eron JJ, et al. Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003-2009. J Acquir Immune Defic Syndr. 2013;63(5):e150\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"320_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nm.4108","volume":"22","author":"SG Deeks","year":"2016","unstructured":"Deeks SG, Lewin SR, Ross AL, et al. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016;22(8):839\u201350.","journal-title":"Nat Med"},{"issue":"3","key":"320_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.immuni.2012.08.010","volume":"37","author":"E Eisele","year":"2012","unstructured":"Eisele E, Siliciano RF. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity. 2012;37(3):377\u201388.","journal-title":"Immunity"},{"issue":"9","key":"320_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1089\/aid.2018.0118","volume":"34","author":"S Castro-Gonzalez","year":"2018","unstructured":"Castro-Gonzalez S, Colomer-Lluch M, Serra-Moreno R. Barriers for HIV cure: the latent reservoir. AIDS Res Hum Retroviruses. 2018;34(9):739\u201359.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"320_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009;15(8):893\u2013900.","journal-title":"Nat Med"},{"issue":"11","key":"320_CR8","doi-asserted-by":"publisher","first-page":"E2575","DOI":"10.1073\/pnas.1720665115","volume":"115","author":"Z Wang","year":"2018","unstructured":"Wang Z, Gurule EE, Brennan TP, et al. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane. Proc Natl Acad Sci U S A. 2018;115(11):E2575\u201384.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"320_CR9","unstructured":"Organization WH. Tuberculosis (TB). https:\/\/www.who.int\/tb\/areas-of-work\/tb-hiv\/en\/"},{"issue":"1","key":"320_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00042560-200109010-00001","volume":"28","author":"Z Toossi","year":"2001","unstructured":"Toossi Z, Johnson JL, Kanost RA, et al. Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation. J Acquir Immune Defic Syndr. 2001;28(1):1\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"320_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1164\/ajrccm.151.1.7812542","volume":"151","author":"C Whalen","year":"1995","unstructured":"Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med. 1995;151(1):129\u201335.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"320_CR12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.157.3.1271","volume":"157","author":"D Goletti","year":"1996","unstructured":"Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol. 1996;157(3):1271\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"320_CR13","first-page":"165","volume":"4","author":"KR Collins","year":"2002","unstructured":"Collins KR, Quinones-Mateu ME, Toossi Z, Arts EJ. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev. 2002;4(3):165\u201376.","journal-title":"AIDS Rev"},{"issue":"7","key":"320_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/gene.2011.29","volume":"12","author":"L Rane","year":"2011","unstructured":"Rane L, Rahman S, Magalhaes I, et al. Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue. Genes Immun. 2011;12(7):513\u201322.","journal-title":"Genes Immun"},{"issue":"21","key":"320_CR15","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1182\/blood-2012-11-465625","volume":"121","author":"C Vandergeeten","year":"2013","unstructured":"Vandergeeten C, Fromentin R, DaFonseca S, et al. Interleukin-7 promotes HIV persistence during antiretroviral therapy. Blood. 2013;121(21):4321\u20139.","journal-title":"Blood"},{"key":"320_CR16","doi-asserted-by":"crossref","unstructured":"Abrahams MR, Joseph SB, Garrett N, et al. The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation. Sci Transl Med. 2019. 11(513).","DOI":"10.1126\/scitranslmed.aaw5589"},{"issue":"8","key":"320_CR17","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/cid\/cix550","volume":"65","author":"CG Adu-Gyamfi","year":"2017","unstructured":"Adu-Gyamfi CG, Snyman T, Hoffmann CJ, et al. Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients. Clin Infect Dis. 2017;65(8):1356\u20138.","journal-title":"Clin Infect Dis"},{"key":"320_CR18","doi-asserted-by":"crossref","unstructured":"Chen J, Xun J, Yang J, et al. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy. Clin Infect Dis. 2018 2018-08-10.","DOI":"10.1093\/cid\/ciy676"},{"key":"320_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12929-014-0102-2","volume":"21","author":"JW Hol","year":"2014","unstructured":"Hol JW, Stolker RJ, Klimek M, Stronks DL, Fekkes D. The tryptophan kynurenine pathway, neopterin and IL-6 during vulvectomy and abdominal hysterectomy. J Biomed Sci. 2014;21:102.","journal-title":"J Biomed Sci"},{"key":"320_CR20","unstructured":"Prevention CFDC. About HIV. https:\/\/www.cdc.gov\/hiv\/basics\/whatishiv.html."},{"issue":"3","key":"320_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/QAI.0000000000001823","volume":"79","author":"A Olson","year":"2018","unstructured":"Olson A, Ragan EJ, Nakiyingi L, et al. Brief Report: Pulmonary Tuberculosis Is Associated With Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Coinfected Ugandans. J Acq Immune Def Syndr. 2018;79(3):407\u201311.","journal-title":"J Acq Immune Def Syndr"},{"issue":"3","key":"320_CR22","first-page":"225","volume":"5","author":"M Badri","year":"2001","unstructured":"Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis. 2001;5(3):225\u201332.","journal-title":"Int J Tuberc Lung Dis"},{"key":"320_CR23","doi-asserted-by":"crossref","unstructured":"Toossi Z, Funderburg NT, Sirdeshmuk S, et al. Systemic immune activation and microbial translocation in dual HIV\/tuberculosis-infected subjects. J Infect Dis. 2013. 207(12):1841-9.","DOI":"10.1093\/infdis\/jit092"},{"issue":"1","key":"320_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1086\/430610","volume":"192","author":"C Rouzioux","year":"2005","unstructured":"Rouzioux C, Hubert JB, Burgard M, et al. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis. 2005;192(1):46\u201355.","journal-title":"J Infect Dis"},{"issue":"2","key":"320_CR25","first-page":"224","volume":"130","author":"ND Wang","year":"2017","unstructured":"Wang ND, Li TS. Factors Associated with the Size of HIV DNA Reservoir. Chin Med J. 2017;130(2):224\u201330.","journal-title":"Chin Med J"},{"issue":"10","key":"320_CR26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/nm.3932","volume":"21","author":"H Janes","year":"2015","unstructured":"Janes H, Herbeck JT, Tovanabutra S, et al. HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders. Nat Med. 2015;21(10):1139\u201341.","journal-title":"Nat Med"},{"issue":"12","key":"320_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.194.12.1711","volume":"194","author":"J Geginat","year":"2001","unstructured":"Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med. 2001;194(12):1711\u20139.","journal-title":"J Exp Med"},{"issue":"11","key":"320_CR28","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1084\/jem.20032083","volume":"199","author":"B Combadiere","year":"2004","unstructured":"Combadiere B, Boissonnas A, Carcelain G, et al. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med. 2004;199(11):1585\u201393.","journal-title":"J Exp Med"},{"key":"320_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-065X.2008.00610.x","volume":"222","author":"JB Katz","year":"2008","unstructured":"Katz JB, Muller AJ, Prendergast GC. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev. 2008;222:206\u201321.","journal-title":"Immunol Rev"},{"issue":"9","key":"320_CR30","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1172\/JCI120549","volume":"128","author":"R Sharaf","year":"2018","unstructured":"Sharaf R, Lee GQ, Sun X, et al. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest. 2018;128(9):4074\u201385.","journal-title":"J Clin Invest"},{"issue":"15","key":"320_CR31","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1097\/QAD.0000000000000734","volume":"29","author":"L Assoumou","year":"2015","unstructured":"Assoumou L, Weiss L, Piketty C, et al. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control. AIDS. 2015;29(15):2003\u20137.","journal-title":"AIDS"},{"key":"320_CR32","first-page":"e3821","volume":"3","author":"JP Williams","year":"2014","unstructured":"Williams JP, Hurst J, Stohr W, et al. HIV-1 DNA predicts disease progression and post-treatment virological control. ELIFE. 2014;3:e3821.","journal-title":"ELIFE"},{"issue":"31","key":"320_CR33","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1073\/pnas.1609057113","volume":"113","author":"H Imamichi","year":"2016","unstructured":"Imamichi H, Dewar RL, Adelsberger JW, et al. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc Natl Acad Sci U S A. 2016;113(31):8783\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"320_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.smim.2014.09.010","volume":"26","author":"MV Rajaram","year":"2014","unstructured":"Rajaram MV, Ni B, Dodd CE, Schlesinger LS. Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol. 2014;26(6):471\u201385.","journal-title":"Semin Immunol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00320-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-020-00320-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00320-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T23:36:52Z","timestamp":1696894612000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-020-00320-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1186\/s12981-020-00320-0","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"25 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethic Committee of Shanghai Public Health Clinical Center. Written informed consent was obtained from each patient before enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}